Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta-analysis, and meta-regression.

ABSTRACT:

Background

The coronavirus disease 2019 (COVID-19) patients with diabetes mellitus (DM) are at high risk of fatal outcomes. This meta-analysis quantifies the prevalence of mortality among (1) diabetic and (2) non-diabetic, and (3) the prevalence of DM, in hospitalized COVID-19 patients.

Methods

Published studies were retrieved from four electronic databases (PubMed, Embase, Scopus, and medRxiv) and appraised critically utilizing the National Heart, Lung, and Blood Institute's tool. Meta-analyses were performed using the random-effects model. The measures of heterogeneity were ascertained by I- squared (I ² ) and Chi-squared (Chi ² ) tests statistics. Predictors of heterogeneity were quantified using meta-regression mod

SUBMITTER: Saha S 

PROVIDER: S-EPMC8012080 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature